Canada markets open in 1 hour 7 minutes

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.38-0.04 (-0.62%)
At close: 04:00PM EDT
6.38 0.00 (0.00%)
Pre-Market: 08:20AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close6.42
Open6.42
Bid6.37 x 100
Ask6.41 x 100
Day's Range6.23 - 6.45
52 Week Range3.80 - 10.90
Volume764,097
Avg. Volume721,226
Market Cap837.464M
Beta (5Y Monthly)1.37
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

    Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, continues its commitment to advancing the cell analysis market by actively participating in key industry gatherings worldwide. The company's Full Spectrum Profiling™ (FSP™) technology, designed for streamlining workflows, expediting discoveries, and enhancing efficiency, will b

  • GlobeNewswire

    Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

    FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8th, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the

  • GlobeNewswire

    Cytek® Biosciences Names William McCombe Chief Financial Officer

    Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies. He was CFO at Velo3D, a leader in m